PGHL — Procter & Gamble Health Income Statement
0.000.00%
Last trade - 00:00
- IN₹79.30bn
- IN₹75.12bn
- IN₹12.30bn
- 96
- 18
- 68
- 69
2018 December 31st | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 18 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,490 | 13,559 | 10,087 | 11,144 | 12,296 |
Cost of Revenue | |||||
Gross Profit | 5,150 | 8,206 | 6,638 | 7,035 | 7,953 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7,220 | 10,667 | 7,923 | 8,733 | 9,330 |
Operating Profit | 1,270 | 2,892 | 2,164 | 2,411 | 2,966 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,580 | 3,549 | 2,333 | 2,534 | 3,142 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,017 | 2,541 | 1,768 | 1,925 | 2,295 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 8,387 | 2,541 | 1,768 | 1,925 | 2,295 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8,387 | 2,541 | 1,768 | 1,925 | 2,295 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 58.4 | 154 | 107 | 119 | 143 |
Dividends per Share | |||||
Special Dividends per Share |